Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012 (2012), Article ID 829650, 7 pages
http://dx.doi.org/10.1155/2012/829650
Research Article

Effect of Magnolol on the Function of Osteoblastic MC3T3-E1 Cells

1Department of Food Science Technology, Yeungnam University, Gyeongsan 712-749, Republic of Korea
2Department of Food & Nutrition, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea

Received 24 August 2011; Accepted 6 November 2011

Academic Editor: Rwei-Fen S. Huang

Copyright © 2012 Eun Jung Kwak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Karsenty and E. F. Wagner, “Reaching a genetic and molecular understanding of skeletal development,” Developmental Cell, vol. 2, no. 4, pp. 389–406, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. S. C. Manolagas, “The role of IL-6 type cytokines and their receptors in bone a,” Annals of the New York Academy of Sciences, vol. 840, pp. 194–204, 1998. View at Google Scholar · View at Scopus
  3. S. L. Teitelbaum, “Bone resorption by osteoclasts,” Science, vol. 289, no. 5484, pp. 1504–1508, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. J. P. Wang, M. F. Hsu, S. L. Raung, C. C. Chen, J. S. Kuo, and C. M. Teng, “Anti-inflammatory and analgesic effects of magnolol,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 346, no. 6, pp. 707–712, 1992. View at Google Scholar · View at Scopus
  5. C. M. Teng, S. M. Yu, C. C. Chen, Y. L. Huang, and T. F. Huang, “EDRF-release and Ca2+-channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta,” Life Sciences, vol. 47, no. 13, pp. 1153–1161, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Fujita and J. Taira, “Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102,” Free Radical Biology and Medicine, vol. 17, no. 3, pp. 273–277, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. J. P. Wang, P. L. Lin, M. F. Hsu, and C. C. Chen, “Possible involvement of protein kinase C inhibition in the reduction of phorbol ester-induced neutrophil aggregation by magnolol in the rat,” Journal of Pharmacy and Pharmacology, vol. 50, no. 10, pp. 1167–1172, 1998. View at Google Scholar · View at Scopus
  8. J. P. Wang, M. F. Hsu, S. L. Raung et al., “Inhibition by magnolol of formylmethionyl-leucyl-phenyl alanine-induced respiratory burst in rat neutrophils,” Journal of Pharmacy and Pharmacology, vol. 51, no. 3, pp. 285–294, 1999. View at Google Scholar · View at Scopus
  9. Y. H. Chen, S. J. Lin, J. W. Chen, H. H. Ku, and Y. L. Chen, “Magnolol attenuates VCAM-1 expression in vitro in TNF-α-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits,” British Journal of Pharmacology, vol. 135, no. 1, pp. 37–47, 2002. View at Google Scholar · View at Scopus
  10. H. Matsuda, T. Kageura, M. Oda, T. Morikawa, Y. Sakamoto, and M. Yoshikawa, “Effects of constituents from the bark of Magnolia obovata on nitric oxide production in lipopolysaccharide-activated macrophages,” Chemical and Pharmaceutical Bulletin, vol. 49, no. 6, pp. 716–720, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. C. W. Kong, K. Tsai, J. H. Chin, W. L. Chan, and C. Y. Hong, “Magnolol attenuates peroxidative damage and improves survival of rats with sepsis,” Shock, vol. 13, no. 1, pp. 24–28, 2000. View at Google Scholar · View at Scopus
  12. H. C. Shih, Y. H. Wei, and C. H. Lee, “Magnolol alters the course of endotoxin tolerance and provides early protection against endotoxin challenge following sublethal hemorrhage in rats,” Shock, vol. 22, no. 4, pp. 358–363, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. H. C. Ou, F. P. Chou, W. H. H. Sheu, S. L. Hsu, and W. J. Lee, “Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells,” Archives of Toxicology, vol. 81, no. 6, pp. 421–432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. S. Lee and E. M. Choi, “Apocynin stimulates osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells,” Cellular Immunology, vol. 270, no. 2, pp. 224–229, 2011. View at Publisher · View at Google Scholar
  15. L. D. Quarles, D. A. Yohay, L. W. Lever, R. Caton, and R. J. Wenstrup, “Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development,” Journal of Bone and Mineral Research, vol. 7, no. 6, pp. 683–692, 1992. View at Google Scholar · View at Scopus
  16. C. G. Bellows, J. E. Aubin, and J. N. M. Heersche, “Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate,” Bone and Mineral, vol. 14, no. 1, pp. 27–40, 1991. View at Publisher · View at Google Scholar · View at Scopus
  17. R. A. Logan, “The role of osteoblasts and osteoclasts in osteogenesis,” American Journal of Orthodontics and Oral Surgery, vol. 28, no. 9, pp. 561–566, 1942. View at Google Scholar · View at Scopus
  18. M. S. Burnstone, “Histochemical observations on enzymatic processes in bones and teeth,” Annals of the New York Academy of Sciences, vol. 85, pp. 431–444, 1960. View at Google Scholar · View at Scopus
  19. J. B. Lian and G. S. Stein, “Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation,” Critical Reviews in Oral Biology and Medicine, vol. 3, no. 3, pp. 269–305, 1992. View at Google Scholar · View at Scopus
  20. O. F. Sendur, Y. Turan, E. Tastaban, and M. Serter, “Antioxidant status in patients with osteoporosis: a controlled study,” Joint Bone Spine, vol. 76, no. 5, pp. 514–518, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. B. M. Abdallah, M. Haack-Sørensen, T. Fink, and M. Kassem, “Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females,” Bone, vol. 39, no. 1, pp. 181–188, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Y. Jiang, R. Shu, Y. F. Xie, and S. Y. Zhang, “Age-related changes in biological characteristics of human alveolar osteoblasts,” Cell Proliferation, vol. 43, no. 5, pp. 464–470, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Maggio, M. Barabani, M. Pierandrei et al., “Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 4, pp. 1523–1527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. O. Altindag, O. Erel, N. Soran, H. Celik, and S. Selek, “Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis,” Rheumatology International, vol. 28, no. 4, pp. 317–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Ning and M. H. Grant, “The role of reduced glutathione and glutathione reductase in the cytotoxicity of chromium (VI) in osteoblasts,” Toxicology in Vitro, vol. 14, no. 4, pp. 329–335, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Chiarugi, M. L. Taddei, N. Schiavone et al., “LMW-PTP is a positive regulator of tumor onset and growth,” Oncogene, vol. 23, no. 22, pp. 3905–3914, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Chiarugi, T. Fiaschi, M. L. Taddei et al., “Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation,” Journal of Biological Chemistry, vol. 276, no. 36, pp. 33478–33487, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. D. L. Lacey, E. Timms, H. L. Tan et al., “Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation,” Cell, vol. 93, no. 2, pp. 165–176, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Jimi, S. Akiyama, T. Tsurukai et al., “Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function,” Journal of Immunology, vol. 163, no. 1, pp. 434–442, 1999. View at Google Scholar · View at Scopus
  30. P. Jezek and L. Hlavata, “Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism,” International Journal of Biochemistry and Cell Biology, vol. 37, no. 12, pp. 2478–2503, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Nishikawa and E. Araki, “Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications,” Antioxidants and Redox Signaling, vol. 9, no. 3, pp. 343–353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. H. Han and W. H. Park, “Growth inhibition in antimycin A treated-lung cancer Calu-6 cells via inducing a G1 phase arrest and apoptosis,” Lung Cancer, vol. 65, no. 2, pp. 150–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Dong, S. Xia, F. Gao, D. Zhang, J. Chen, and J. Zhang, “3,3′-Diindolylmethane attenuates experimental arthritis and osteoclastogenesis,” Biochemical Pharmacology, vol. 79, no. 5, pp. 715–721, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Gilbert, X. He, P. Farmer et al., “Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2αA) is inhibited by tumor necrosis factor-α,” Journal of Biological Chemistry, vol. 277, no. 4, pp. 2695–2701, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Kaneki, R. Guo, D. Chen et al., “Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts,” Journal of Biological Chemistry, vol. 281, no. 7, pp. 4326–4333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. F. J. Hughes and G. L. Howells, “Interleukin-6 inhibits bone formation in vitro,” Bone and Mineral, vol. 21, no. 1, pp. 21–28, 1993. View at Google Scholar · View at Scopus
  37. M. A. Fang and T. J. Hahn, “Effects of interleukin-6 on cellular function in UMR-106-01 osteoblastlike cells,” Journal of Bone and Mineral Research, vol. 6, no. 2, pp. 133–139, 1991. View at Google Scholar · View at Scopus